Reticulon-4 receptor-like 1 (RTN4RL1), also known as Reticulon 4 Receptor Like 1, is a protein-coding gene . The RTN4RL1 gene is associated with certain diseases, including microcephaly and epilepsy .
Nomenclature The official full name is Reticulon 4 Receptor Like 1, and the symbol is RTN4RL1 .
External Links RTN4RL1 has links to bioinformatics resources such as OMIM (610461), NCBI Entrez Gene (146760), and UniProt (Q86UN2) . Genome browsers like Ensembl and UCSC also provide information .
The COSMIC database provides information regarding the distribution of mutations across primary tissue types . This includes data from targeted and whole genomes/exome resequencing, where all protein-coding genes are screened for mutations .
COSMIC Data The COSMIC (Catalogue Of Somatic Mutations In Cancer) database contains a variety of data on mutations, including single base substitutions, complex mutations, and insertions and deletions .
Mutation Types The types of mutations observed in samples for this gene are summarized in charts, with the number of samples recorded as having a particular type of mutation . A sample may have more than one type of mutation .
LOVD Data The Global Variome shared Leiden Open Variation Database (LOVD) lists all variants in the RTN4RL1 gene, described using the NM_178568.2 transcript reference sequence .
RTN4RL1 is associated with drug resistance mutations . Alternative transcripts are displayed for genes where reported resistant mutations are not located on the canonical transcript but are on the alternative, and also where reported resistant mutations are located at the same genomic position on both the canonical and alternative transcripts or on overlapping genes and/or fusions and share a COSMIC ID .
Research has explored the use of Retinol-Binding Protein 4 (RBP4) antagonists in the context of retinal diseases .
RBP4 Antagonists and Bisretinoid Formation Lipofuscin bisretinoids contribute to the pathogenesis of macular degeneration . RBP4 antagonists can reduce serum retinol concentrations, which reduces retinol delivery to the retina and decreases bisretinoid synthesis .
BPN-14136 BPN-14136 is an RBP4 antagonist with good in vitro potency and selectivity and optimal rodent pharmacokinetic characteristics . Studies have been conducted to evaluate its pharmacokinetics (PK) and pharmacodynamics (PD) in dogs and non-human primates (NHP) . BPN-14136 exhibited a favorable PK profile in both species, with dose-normalized exposure being significantly higher in NHP than in dogs . Oral administration of BPN-14136 to NHP induced a strong 99% serum RBP4 reduction .
| Mutation (Amino Acid) | Mutation ID (COSF) | Count | Mutation Type |
|---|---|---|---|
| (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) |
| Sample Name | Sample ID | Probe ID | Probe Posn. | Type High (Hypermethylation); Beta-Value > 0.8 and differs from normal average by > 0.5 Low (Hypomethylated); Beta-Value < 0.2 and differs from normal average by > 0.5 | Level (Beta-Value) | Normal Average | Study |
|---|---|---|---|---|---|---|---|
| (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) | (Data not provided in the available context) |
Reticulon-4 receptor-like 1 (Rtn4rl1) is a cell surface receptor with functionally redundant roles in postnatal brain development and adult central nervous system axon regeneration. It contributes to normal axon migration across the brain midline and corpus callosum formation. Rtn4rl1 protects motoneurons from apoptosis, potentially via MAG mediation. It inhibits neurite outgrowth and axon regeneration by binding to neuronal chondroitin sulfate proteoglycans. Furthermore, it binds heparin and, like other family members, regulates dendritic spine and synapse number during brain development. Its signaling activates Rho, leading to actin cytoskeleton reorganization.
Rtn4rl1 (also known as NgR3) is a GPI-anchored leucine-rich repeat (LRR) protein that functions as part of the NoGo receptor family. The protein consists of:
An N-terminal LRR domain
Eight LRR repeats
A cysteine-rich C-terminal region
A GPI anchor domain
The mature mouse Rtn4rl1 protein has a molecular weight of approximately 49 kDa (calculated) but migrates at approximately 65 kDa in SDS-PAGE due to glycosylation . Its primary function appears to be regulating axonal regeneration and plasticity in the adult central nervous system, similar to other family members .
All three RTN4 receptor family members (RTN4R, RTN4RL1, and RTN4RL2) share similar binding domains but exhibit distinct affinities for ligands:
| Receptor | Primary Ligands | Binding Affinity Range | Key Binding Domains |
|---|---|---|---|
| RTN4R (NgR1) | RTN4/Nogo, MAG, OMgp | 1.9-30 nM | Leucine-rich repeat domain |
| RTN4RL1 (NgR3) | BAI1, BAI3 | 5-50 nM | Leucine-rich repeat domain |
| RTN4RL2 (NgR2) | MAG | 10-100 nM | Leucine-rich repeat domain |
The binding properties differ primarily in their affinity for specific ligands. For example, RTN4R shows the strongest binding to BAI3 (Kd = 1.9 nM), while Rtn4rl1 has intermediate binding affinities to its ligands . These differences likely contribute to their distinct roles in neuronal development and function.
For successful expression and purification of recombinant mouse Rtn4rl1:
Expression System Options:
Mammalian expression (HEK293 cells) yields the most physiologically relevant protein with proper glycosylation
E. coli systems can be used for fragments lacking glycosylation sites
Purification Protocol:
For His-tagged constructs: Use Ni-NTA affinity chromatography in PBS buffer (pH 7.2-7.4)
Include 10% glycerol in storage buffers to maintain stability
Consider adding protease inhibitors during lysis to prevent degradation
For cell-surface expressed Rtn4rl1, consider using phosphatidylinositol-specific phospholipase C (PI-PLC) to release the GPI-anchored protein
Storage Conditions:
Store at -20°C for short term (up to one month)
For long-term storage, maintain at -80°C in buffer containing 25 mM Tris-HCl, 100 mM glycine, pH 7.3, with 10% glycerol
Avoid repeated freeze-thaw cycles
When designing experiments:
For Western blot applications, reducing conditions may affect epitope recognition; test both reducing and non-reducing conditions
For binding studies, consider using SPR or cell-adhesion assays, which have demonstrated high sensitivity for Rtn4rl1 interactions
For in vivo studies, consider using Rtn4rl1 knockout models to validate antibody specificity
The interaction between BAI adhesion-GPCRs and Rtn4rl1 involves specific structural domains with unusual glycoconjugates mediating high-affinity binding:
Key Interaction Features:
The single thrombospondin type 1-repeat (TSR) domain of BAIs binds to the leucine-rich repeat domain of Rtn4rl1 with nanomolar affinity
C-mannosylation of tryptophan and O-fucosylation of threonine in the BAI TSR domains are critical for creating the interface that enables high-affinity interactions
Critical Residues:
In BAI1: Arg430, Leu420, and Thr424 (O-fucosylation site) are essential for binding
In RTN4 receptors: His210, Tyr254, and Arg256 are critical for the interaction
Mutation studies have shown that:
The Thr424Val mutation that blocks O-fucosylation of BAI1 abolishes binding
The Trp418Phe mutation in BAI1 produces a partial decrease in binding
Mutations of critical interface residues (Arg430Ala, Leu420Ala in BAI1; His210Ala, Tyr254Ala, Arg256Ala in RTN4R) abolish complex formation
This molecularly unusual interface represents a new paradigm for protein-protein interactions involving glycoconjugates as essential structural components.
Rtn4rl1 signaling involves several key pathways that regulate neuronal development and function:
RhoA Activation Pathway:
Rtn4rl1 binding to ligands activates RhoA GTPase
Activated RhoA inhibits axonal growth through cytoskeletal reorganization
This pathway is shared with other RTN4 receptor family members
p75NTR Co-receptor Signaling:
Synaptic Development Regulation:
The physiological outcomes of these signaling pathways include:
Regulation of dendritic spine morphology
Control of synaptic strength
Modulation of axonal growth and regeneration
Influence on neuronal network activity
Rtn4rl1 undergoes several important post-translational modifications that impact its function:
N-Glycosylation:
Glycosylation contributes to protein folding, stability, and ligand recognition
Deglycosylation experiments show that N-glycans contribute to the apparent molecular weight shift from 49 kDa (calculated) to 65 kDa (observed in SDS-PAGE)
Phosphorylation:
Phosphorylation sites have been identified at S276, S277, and S278
These modifications may regulate protein-protein interactions and signaling
GPI Anchoring:
As a GPI-anchored protein, Rtn4rl1 localizes to lipid rafts in the plasma membrane
This localization is critical for its function in signaling complexes
Methodological Approach for Studying PTMs:
Use site-directed mutagenesis to create point mutations at key modification sites
Compare wild-type and mutant protein function in binding assays and cellular models
Employ mass spectrometry to identify and quantify specific modifications
Use enzymatic treatments (PNGase F for N-glycans, PI-PLC for GPI anchors) to assess the functional impact of specific modifications
Studies of Rtn4rl1 knockout mice have revealed several important phenotypes:
Neuronal Development:
Increased axonal and dendritic arborization
Altered synapse formation
Changes in neuronal network activity
Electrophysiological Changes:
Significant reduction in network activity
Decrease in synaptic transmission
Alterations in long-term potentiation (LTP) and depression (LTD)
Behavioral Phenotypes:
Subtle changes in learning and memory performance
Altered response to injury in the central nervous system
Rescue Experiments:
Wild-type Rtn4rl1, but not binding-deficient mutants, can rescue these phenotypes in knockout neurons, highlighting the functional importance of its ligand interactions .
| Property | Recombinant Rtn4rl1 | Native Neuronal Rtn4rl1 |
|---|---|---|
| Glycosylation | Depends on expression system; full in mammalian cells | Complex N-glycans with tissue-specific patterns |
| Membrane Association | Soluble unless produced with GPI anchor | GPI-anchored in lipid rafts |
| Co-receptor Interactions | Limited unless co-expressed | Forms complexes with p75NTR and other co-receptors |
| Binding Affinity | Measurable by SPR (nanomolar range) | May be enhanced by clustering in membrane microdomains |
| Signaling Capacity | Limited unless in cellular context | Integrated into signaling networks |
When designing experiments:
Consider using cell membrane preparations rather than soluble proteins for more physiologically relevant binding studies
Use techniques like FRET or proximity ligation assays to study interactions in their native context
Compare binding properties of recombinant proteins produced in different expression systems to understand the impact of post-translational modifications
Rtn4rl1 shows significant conservation across mammalian species, with more divergence in non-mammalian vertebrates:
Evolutionary analysis suggests:
The core ligand-binding LRR domain is highly conserved across species
The greatest sequence divergence occurs in the C-terminal region
Glycosylation sites show variable conservation, suggesting species-specific regulation
When designing cross-species experiments:
Human antibodies may cross-react with mouse Rtn4rl1 due to high sequence similarity
Consider species-specific differences when interpreting binding studies or functional assays
The human RTN4RL1 control fragment (aa 279-391) shares 74% sequence identity with the corresponding mouse region
| Property | Rtn4rl1 (NgR3) | RTN4R (NgR1) | RTN4RL2 (NgR2) |
|---|---|---|---|
| Primary Ligands | BAI adhesion-GPCRs | Nogo-A, MAG, OMgp | MAG |
| Expression Pattern | Neurons | Neurons | Neurons |
| Effect on Axonal Growth | Inhibitory | Strongly inhibitory | Moderately inhibitory |
| Role in Synapse Formation | Regulatory | Regulatory | Regulatory |
| Knockout Phenotype | Altered synapse formation and neuronal arborization | More severe defects in axonal regeneration | Protection of motoneurons against apoptosis |
All three receptors share structural similarities with leucine-rich repeat domains, but they exhibit distinct ligand binding preferences and functional roles in the nervous system. The combined action of these receptors likely provides redundancy and specificity in regulating neuronal development and regeneration.